AstraZeneca plc (AZN) has fallen 0.29% Wednesday In Premarket Trading

AstraZeneca plc (AZN) is lower by Wednesday morning, with the stock declining -0.29% in pre-market trading to 57.68. AZN's short-term technical score of 52 indicates that the stock has traded more bullishly over the last month than 52% of stocks on the market. In the Drug Manufacturers - General industry, which ranks 88 out of 146 industries, the stock ranks higher than 52% of stocks. AstraZeneca plc has risen 0.36% over the past month, closing at $58.65 on December 29. During this period of time, the stock fell as low as $56.67 and as high as $60.62. AZN has an average analyst recommendation of Strong Buy. The company has an average price target of $67.73.

AZN has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on AZN!

See Full AZN Report

AstraZeneca plc has a Long-Term Technical rank of 59. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 41% of the market scoring higher. In the Drug Manufacturers - General industry which is number 47 by this metric, AZN ranks better than 37% of stocks.

Important Dates for Investors in AZN:

-AstraZeneca plc is set to release earnings on 2/10/2022. During their last earnings release the company posted EPS of $0.95. -We do not have a set dividend date for AstraZeneca plc at this time. Click Here To Get The Full Report on AstraZeneca plc (AZN)